Get the Stockscreener App
4.01
3.61%
-0.15
After Hours:
4.09
0.08
+2.00%
Qualigen Therapeutics Inc stock is traded at $4.01, with a volume of 115.55K.
It is down -3.61% in the last 24 hours and up +91.41% over the past month.
Qualigen Therapeutics Inc is an early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's program, QN-302, is an investigational small-molecule G-quadruplexes (G4)-selective transcription inhibitor with binding affinity to G4s prevalent in cancer cells.
See More
Previous Close:
$4.16
Open:
$4.14
24h Volume:
115.55K
Relative Volume:
0.05
Market Cap:
$6.80M
Revenue:
$4.79M
Net Income/Loss:
$-13.42M
P/E Ratio:
-1.5075
EPS:
-2.66
Net Cash Flow:
$-10.30M
1W Performance:
-20.28%
1M Performance:
+91.41%
6M Performance:
+33.67%
1Y Performance:
-52.23%
1-Day Range:
$4.01
$4.2697
1-Week Range:
$4.01
$5.2816
52-Week Range:
$1.61
$10.45
Qualigen Therapeutics Inc Stock (QLGN) Company Profile
Name
Qualigen Therapeutics Inc
Sector
Industry
Phone
(760) 918-9165
Address
2042 CORTE DEL NOGAL, CALIFORNIA
Compare QLGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
QLGN
Qualigen Therapeutics Inc
|
4.01 | 8.46M | 4.79M | -13.42M | -10.30M | -2.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Qualigen Therapeutics Inc Stock (QLGN) Latest News
Applying Wyckoff theory to Qualigen Therapeutics Inc. stockJuly 2025 Breakouts & Safe Entry Point Identification - newser.com
Why Qualigen Therapeutics Inc. stock is trending among retail tradersShare Buyback & Verified Momentum Stock Ideas - newser.com
Why Qualigen Therapeutics Inc. is moving todayTrade Analysis Summary & Weekly Top Performers Watchlists - newser.com
Qualigen Therapeutics, Inc. (QLGN) Stock: Poised for Rebound as CXC10 Launches Crypto Asset Treasury Amid Market Turmoil - parameter.io
Multi asset correlation models including Qualigen Therapeutics Inc.Market Risk Analysis & Expert-Curated Trade Recommendations - newser.com
Qualigen Therapeutics, Inc. Launches C10 Cryptocurrency Asset Treasury Purchases Amid Crypto Market Volatility - Quiver Quantitative
$16B Liquidated in Crypto Sell-Off — Qualigen Launches C10 Treasury Buying Program Next Week - Stock Titan
Qualigen Therapeutics Announces the Official Launch of C10 Cryptocurrency Asset Treasury (DAT) Purchases: Why Is This Pullback the Golden Moment CXC10 Has Been Waiting For? - GlobeNewswire Inc.
What machine learning models say about Qualigen Therapeutics Inc.2025 EndofYear Setup & Accurate Entry and Exit Point Alerts - newser.com
Can technical indicators confirm Qualigen Therapeutics Inc.’s reversalMarket Rally & Consistent Growth Equity Picks - newser.com
How to integrate Qualigen Therapeutics Inc. into portfolio analysis toolsJuly 2025 PreEarnings & Scalable Portfolio Growth Ideas - newser.com
What technical models suggest about Qualigen Therapeutics Inc.’s comeback - newser.com
Can machine learning forecast Qualigen Therapeutics Inc. recoveryJuly 2025 Sector Moves & Consistent Profit Trade Alerts - newser.com
How to read the order book for Qualigen Therapeutics Inc.Trade Exit Summary & Detailed Earnings Play Alerts - newser.com
How to monitor Qualigen Therapeutics Inc. with trend dashboardsJuly 2025 Patterns & Weekly Top Gainers Trade List - newser.com
Qualigen Therapeutics, Inc. Announces Leadership and Governance Changes to Support Strategic Growth - Quiver Quantitative
Qualigen Therapeutics appoints Jerry Wang as co-CEO, Koti Meka as CFO - MarketScreener
Qualigen Therapeutics (NASDAQ: QLGN) Announces Executives, - GlobeNewswire
Qualigen Therapeutics (NASDAQ: QLGN) Announces Executives, Board of Directors Appointments and Auditor Transition - MarketScreener
Co-CEO Jerry Wang & CFO Koti Meka join Qualigen; Board adds 3 directors and auditor switches to MGO for FY2025 - Stock Titan
How to recover losses in Qualigen Therapeutics Inc. stockJuly 2025 Big Picture & Trade Opportunity Analysis - newser.com
Will Qualigen Therapeutics Inc. stock maintain growth storyJuly 2025 News Drivers & Proven Capital Preservation Tips - newser.com
Will Qualigen Therapeutics Inc. (7R90) stock recover faster than industrySwing Trade & AI Based Buy/Sell Signal Reports - newser.com
Qualigen Therapeutics Secures $41M for Crypto Transformation - TipRanks
Will Qualigen Therapeutics Inc. (7R90) stock hit analyst forecastsWeekly Investment Summary & Daily Volume Surge Trade Alerts - newser.com
Faraday Future Announces Closing of Strategic $41 Million Investment in Qualigen Therapeutics (NASDAQ: QLGN) to Accelerate its Dual-Flywheel & Dual-Bridge Eco Strategy - ADVFN
Univest Securities, LLC Announces Closing of $41 Million Strategic Investment in Client Qualigen Therapeutics (NASDAQ: QLGN) from Client Faraday Future (NASDAQ: FFAI) - ADVFN
Faraday Future Announces Strategic $41 Million Investment in Qualigen Therapeutics, Inc. (NASDAQ: QLGN) for Crypto Business Through PIPE Transaction - ADVFN
Qualigen Therapeutics Announces Successful Closing of $41 Million PIPE Financing Led by Faraday Future, Accelerating New Business Transformation into Crypto - ADVFN
Faraday Future Announced a Total Strategic Investment of $41 million in Qualigen Therapeutics, Inc. (NASDAQ: QLGN) During its Annual 919 Event, for its Crypto Business Focusing on Three Growth Engines - ADVFN
Faraday Future’s $41M Investment in Qualigen for Web3 - MSN
Qualigen to invest in NanoSynex, stock tumbles 21% - MSN
Faraday Future completes $41 million investment in Qualigen By Investing.com - Investing.com Nigeria
Faraday Future completes $41 million investment in Qualigen Therapeutics By Investing.com - Investing.com Nigeria
Univest Securities, LLC Announces Closing of $41 Million - GlobeNewswire
Qualigen Therapeutics, Inc. announced that it has received $41 million in funding from Faraday Future Intelligent Electric Inc., Sequoia Capital, IDgo, Inc and other investor. - MarketScreener
Univest Securities announces closing of $41 million strategic investment in client Qualigen Therapeutics - MarketScreener
Qualigen Therapeutics Inc Stock (QLGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):